<p>Mark Prausnitz of Georgia Institute of Technology and Steve Oberste of the Centers for Disease Control and Prevention in the U.S. will test the feasibility of using microneedle patches to deliver the inactivated polio vaccine (IPV) instead of using intramuscular vaccine shots. This new method is designed to lower the required dose, simplify vaccination procedures, and eliminate dangers associated with hypodermic needles.</p>


Mark Prausnitz of Georgia Institute of Technology and Steve Oberste of the Centers for Disease Control and Prevention in the U.S. will test the feasibility of using microneedle patches to deliver the inactivated polio vaccine (IPV) instead of using intramuscular vaccine shots. This new method is designed to lower the required dose, simplify vaccination procedures, and eliminate dangers associated with hypodermic needles.

Microneedle Patch for Low-Cost, Intradermal IPV Vaccination

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.